查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493210

週边血管装置市场规模、份额、趋势分析报告：按类型、地区、细分市场预测，2024-2030 年

Peripheral Vascular Devices Market Size, Share & Trends Analysis Report By Type (Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

週边血管装置市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球週边血管器械市场规模将达到148.39亿美元，2024年至2030年复合年增长率为6.1%。

推动市场成长的主要因素之一是静脉疾病或慢性静脉功能不全（CVI）盛行率的上升。老年人口的增加、微创血管内手术需求的增加、新产品的推出以及主要市场参与企业为扩大业务而进行的合併和联盟也是推动市场成长的一些因素。

IVC过滤器、血流动力学调节装置、EVAR血管支架、血管造影术导管和流行调节装置是周边血管内手术、冠状动脉手术以及周边动脉疾病和冠状动脉疾病治疗中使用的一些设备。这些仪器在手术过程中使用，以最大限度地减少对患者的干扰。对治疗血管疾病的微创手术的需求不断增长，对周围血管装置的市场需求产生了显着影响。患者往往更喜欢微创手术，因为它可以加速或帮助癒合过程，减少对患者的创伤，并缩短住院时间。

例如，2020 年 2 月，为大凤凰城地区 160 万居民提供服务的硅谷首屈一指的医疗保健提供者 Honor Health 宣布，其心血管卓越中心因周边动脉疾病(PAD) 获得认可。周边动脉疾病是一种常见的心血管疾病，在美国影响超过 1000 万人。作为 DETOUR II 临床试验的一部分，一名股动脉完全闭塞的患者接受了手术。治疗方法是经皮（皮肤穿刺）搭桥手术。多达 200 名患者参与了这项研究，该研究可能会核准美国 的食品药物管理局。对晚期 PAD 患者进行了腿部无切口的经皮经皮手术。因此，与传统方法相比，此类手术侵入性较小，并可能带来更高的风险。在DETOUR II治疗中，透过血管支架绕过股动脉受损部分，基本上提供了一条旁路，让血液再次自由流向患者的小腿。

此外，微创手术往往可以最大限度地减少术后併发症并降低死亡率。其中一些手术，例如球囊血管成形术、药物释放型技术、动脉粥状硬化斑块切除术和雷射消熔，对于改善生活品质非常重要。因此，这些优势预计将增加週边血管装置的市场需求。

患者意识的提高和医疗保健支出的提高，以及对微创手术的接受度的提高，都有助于扩大市场占有率。此外，整个行业预计将受益于医疗保健基础设施的快速扩张和新兴地区医疗保健支出的增加。此外，主要企业推出的新颖产品正在推动市场发展。例如，2022年1月，库克医疗的新型膝下药物释放型支架（BTK）被美国食品药物管理局（FDA）授予突破性器材分类。这项创新旨在治疗危及四肢的持续缺血患者。

週边血管器械市场报告亮点

  • 按类型划分，外周支架细分市场占据最大的市场份额，2023年销售份额为26.0%。这是由于支架技术的改进和微创手术的采用增加。
  • 按类型划分，外围配件领域预计在预测期内将以最快的复合年增长率成长。这是因为市场上有许多周边配件供应商，而印度和中国等新兴国家正在以低成本供应这些产品。除此之外，由于术后风险和併发症较少，对球囊血管成形术中使用的球囊充气装置的需求正在增加，这进一步推动了市场的成长。
  • 北美在2023年占据市场主导地位，销售份额为39.52%。该市场受到心血管疾病盛行率上升和老年人口增长等因素的推动。
  • 预计亚太地区在预测期内的复合年增长率将是最快的。这是由于公众对该地区快速诊断和治疗需求的认识不断提高，以及週边血管和心臟病学技术的进步。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章週边血管器械市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 週边血管器械市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章週边血管器械市场：类型估计与趋势分析

  • 週边血管器械市场：类型仪表板
  • 週边血管器械市场：类型变化分析
  • 2018-2030 年按类型分類的周边血管器械市场规模、预测与趋势分析
  • 外周支架
  • PTA球囊
  • 导管
  • 血管内动脉瘤修补血管支架
  • 斑块矫正装置
  • 周边设备配件
  • 下腔静脉滤器
  • 血流动力学血流调节器

第五章週边血管装置市场：按国家和类型分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测及趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第六章 竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Abbott
    • Edward Lifesciences Corporation
    • Medtronic
    • Teleflex Incorporated
    • Boston Scientific Corporation
    • WL Gore &Associates, Inc.
    • Boston Scientific Corporation
    • Cook Group Inc.
    • Covidien
Product Code: 978-1-68038-237-2

Peripheral Vascular Devices Market Growth & Trends:

The global peripheral vascular devices market size is expected to reach USD 14,839.0 million by 2030 and is projected to grow at a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the main factors propelling the market growth is the rising prevalence of venous disorders or Chronic Venous Insufficiency (CVI). Its adoption is also being accelerated by the growing elderly population and the rising demand for minimally invasive endovascular operations, novel product launch, mergers, and collaborations by the key market players for business expansion are some of the factors that boosts the market growth.

IVC filters, hemodynamic flow alteration, EVAR stent-grafts, angiography catheters, and plague modification devices are some of the devices utilized in peripheral endovascular and coronary procedures, as well as for treating peripheral arterial or coronary arterial disease. These tools are used during surgery to reduce patient interference with the least amount of disruption. The market demand for peripheral vascular devices is significantly influenced by the rising need for less invasive procedures for the treatment of vascular disease. Patients are more likely to prefer minimally invasive procedures since they speed up or aid the healing process, lessen patient trauma, and necessitate shorter hospital stays.

For instance, in February 2020, HonorHealth, a premier healthcare provider in the Valley that provides care to 1.6 million residents of the greater Phoenix area, announced today that its Cardiovascular Center of Excellence has made a significant advancement in the treatment of peripheral arterial disease (PAD). It is a common cardiovascular condition that affects more than 10 million people in the country. A patient with a completely blocked femoral artery underwent surgery as part of a DETOUR II clinical trial. The treatment was a percutaneous (skin puncture) bypass. Up to 200 patients were accepted for the research, which might result in FDA approval for the treatment. Without cutting open or making incisions in the leg, a peripheral percutaneous bypass procedure was conducted on a patient with advanced PAD. This makes such surgery minimal invasive and possibly riskier than the conventional approach. The DETOUR II treatment involved the use of stent grafts that run via the femoral vein, bypassing the damaged section of the femoral artery and, in essence, providing a bypass so that blood can flow freely to the patient's lower limb once more.

Moreover, minimally invasive procedures tend to minimize the post-surgery complications and reduce the mortality rates. Some of these procedures including balloon angioplasty, drug-eluting technologies, excisional atherectomy or laser ablation are significant in improving quality of life. As a result, these advantages are anticipated to raise market demand for peripheral vascular devices.

Increased patient awareness and healthcare spending, as well as higher acceptance rates of minimally invasive surgery, all contribute to its significant market share. In addition, the industry as a whole is anticipated to benefit from the rapid expansion of healthcare infrastructure and rising healthcare spending in emerging regions. Moreover, novel product launches by the key players boost the market. For instance, in January 2022, a new drug-eluting stent for below the knee (BTK) manufactured by Cook Medical was given Breakthrough Device classification by the US Food and Drug Administration (FDA). This innovation is meant to treat patients with persistent ischemia that poses a hazard to their limbs.

Peripheral Vascular Devices Market Report Highlights:

  • Based on type, the peripheral stents segment held the market with the largest revenue share of 26.0% in 2023, owing to the improvements in stent technology and the rising adoption of less invasive procedures
  • Based on type, the peripheral accessories segment is anticipated to grow at the fastest CAGR over the forecast period. This is due to the presence of larger number of suppliers of peripheral accessories in the market as well as developing countries such as India and China offering low-cost supplies for these products. In addition to this, there is increasing demand for balloon inflation devices used for balloon angioplasty owing to the less risk and complications post-surgery, which is further driving the market growth
  • North America dominated the market with the revenue share of 39.52% in 2023. The market is driven by factors like the rising prevalence of cardiovascular disorders and the growing elderly population
  • Asia Pacific is anticipated to witness at the fastest CAGR over the forecast period. This is due to the increased public awareness of the need for prompt diagnosis and treatment, as well as improvements in peripheral vascular and cardiology technology in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Parent market analysis (Model 2)
    • 1.7.4. Approach 2: Parent market analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market outlook
  • 2.2. Segment outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Peripheral Vascular Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of PAD
      • 3.2.1.2. Increasing clinical trials and studies
      • 3.2.1.3. Novel product launch
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment and device
      • 3.2.2.2. Product recalls
  • 3.3. Peripheral Vascular Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Peripheral Vascular Devices Market: Type Estimates & Trend Analysis

  • 4.1. Peripheral Vascular Devices Market: Type Dashboard
  • 4.2. Peripheral Vascular Devices Market: Type Movement Analysis
  • 4.3. Peripheral Vascular Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Peripheral Stents
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.1. Iliac Artery Stents
      • 4.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Femoral Artery Stents
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Carotid Artery Stents
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.4. Renal Artery Stents
      • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.5. Other Peripheral Stents
      • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. PTA Balloons
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Catheters
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.1.1. Angiography Catheters
      • 4.6.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.1.2. Guiding Catheters
      • 4.6.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.6.1.3. IVUS/OCT Catheters
      • 4.6.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Endovascular Aneurysm Repair Stent Grafts
    • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.7.1.1. Thoracic Endovascular Aneurysm Stent Grafts
      • 4.7.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.7.1.2. Abdominal Endovascular Aneurysm Stent Grafts
      • 4.7.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Plaque Modification Devices
    • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.8.1.1. Atherectomy Devices
      • 4.8.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.8.1.2. Thrombectomy Devices
      • 4.8.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Peripheral Accessories
    • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.1. Guidewires
      • 4.9.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.2. Peripheral Vascular Closure Devices
      • 4.9.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.3. Balloon Inflation Devices
      • 4.9.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.9.1.4. Introducer Sheaths
      • 4.9.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Inferior Vena Cava Filters
    • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11. Hemodynamic Flow Alteration Devices
    • 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Peripheral Vascular Devices Market: Regional Estimates & Trend Analysis by Country, Type

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Sweden
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Regulatory framework/ reimbursement structure
      • 5.4.9.3. Competitive scenario
      • 5.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. China
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Thailand
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2023
    • 6.3.4. Abbott
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Edward Lifesciences Corporation
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Medtronic
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Teleflex Incorporated
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Boston Scientific Corporation
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. W. L. Gore & Associates, Inc.
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Boston Scientific Corporation
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Cook Group Inc.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Covidien
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Volume Price Analysis
  • Fig. 8 Peripheral Vascular Devices market snapshot (2023)
  • Fig. 9 Peripheral Vascular Devices market segmentation
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Peripheral Vascular Devices market: Type movement analysis
  • Fig. 15 Peripheral Vascular Devices market: Type outlook and key takeaways
  • Fig. 16 Peripheral Stents market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 17 Iliac Artery Stents market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 18 Femoral Artery Stents market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 19 Carotid Artery Stentsmarket size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 20 Renal Artery Stents market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 21 Other Peripheral Stentsmarket size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 22 PTA Balloons market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 23 Catheters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 24 Angiography Catheters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 25 Guiding Catheters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 26 IVUS/OCT Catheters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 27 Endovascular Aneurysm Repair Stent Grafts market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 28 Thoracic Endovascular Aneurysm Stent Grafts market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 29 Abdominal Endovascular Aneurysm Stent Grafts market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 30 Plaque Modification Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 31 Atherectomy Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 32 Thrombectomy Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 33 Peripheral Accessories market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 34 Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 35 Peripheral Vascular Closure Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 36 Balloon Inflation Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 37 Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 38 Frontline Finesse Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 39 Extra Support Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 40 Workhorse Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 41 Specialty Guidewires market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 42 Inferior Vena Cava Filters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 43 Permanent Filters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 44 Retrievable Filters market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 45 Hemodynamic Flow Alteration Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 46 Chronic Total Occlusion Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 47 Embolic Protection Devices market size & forecasts and trend analysis, 2018 - 2030 (USD Million)
  • Fig. 48 Peripheral Vascular Devices market, by region, 2018 - 2030 (USD Million)
  • Fig. 49 North America market, 2018 - 2030 (USD Million)
  • Fig. 50 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 51 Canada market, 2018 - 2030 (USD Million)
  • Fig. 52 Europe market, 2018 - 2030 (USD Million)
  • Fig. 53 UK market, 2018 - 2030 (USD Million)
  • Fig. 54 Germany market, 2018 - 2030 (USD Million)
  • Fig. 55 France market, 2018 - 2030 (USD Million)
  • Fig. 56 Italy market, 2018 - 2030 (USD Million)
  • Fig. 57 Spain market, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark market, 2018 - 2030 (USD Million)
  • Fig. 59 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 60 Norway market, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 62 China market, 2018 - 2030 (USD Million)
  • Fig. 63 India market, 2018 - 2030 (USD Million)
  • Fig. 64 Japan market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia market, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 70 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 72 MEA market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE market, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait market, 2018 - 2030 (USD Million)